Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKore Potash PLC Regulatory News (KP2)

Share Price Information for Kore Potash PLC (KP2)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.20 (7.14%)
Bid:
2.90
Ask:
3.10
Spread: 0.20 (6.897%)
Market Cap: £155.28m
KP2 Live PriceLast checked at - London Stock Exchange

Intraday Kore Potash PLC Share Chart

Draft non-binding financing Term Sheet received

28 Apr 2025 15:23

RNS Number : 4855G
Kore Potash PLC
28 April 2025
 

28 April 2025

 

Kore Potash Plc

("Kore Potash" or the "Company")

Draft non-binding financing Term Sheet received

 

Kore Potash (AIM: KP2, ASX: KP2, JSE: KP2, A2X: KP2), the potash development company with 97% ownership of the Kola Potash Project ("Kola" or the "Kola Project") and Dougou Extension ("DX") Potash Project in the Sintoukola Basin, located in the Republic of Congo ("RoC"), is pleased to announce that, in line with previous communications, it has today received the draft financing proposal and associated draft non-binding term sheets ("Term Sheets") for the Kola Project, from the Summit Consortium ("Consortium").

 

The draft financing proposal and associated Term Sheets are comprehensive and cover the full funding requirement for the development of the Kola Project, underpinned by a combination of royalty and project finance components. Kore Potash has until 31 May 2025 to consider, negotiate if necessary and settle on the terms, following which more specific and definitive information, as appropriate, will be shared with the market.

 

The parties have agreed that no details of the proposed financing will be disclosed until the initial terms set out in the Term Sheets have been finalised, agreed and executed.

 

The Company retains the right not to accept any finance proposal presented by the Consortium and there is no guarantee that any final proposal or legally binding agreement will be forthcoming. The Company provides no assurance to shareholders that the Consortium will provide the financing required on terms which are deemed acceptable to the Company. If the Consortium does not provide an acceptable financing package leading to binding legal documentation being entered into, the Company will need to explore other debt, equity and structured finance alternatives

 

Further details about the financing arrangements will be notified to the market in accordance with the Company's continuous disclosure obligations.

 

Enquiries:

 

Kore Potash

Tel: +44 (0) 20 3963 1776

 

Andre Baya - CEO

Andrey Maruta - CFO

 

SP Angel - Nomad and Joint Broker

 

Tel: +44 (0) 20 7470 0470

Ewan Leggat

Charlie Bouverat

Grant Barker

 

Shore Capital - Joint Broker

Tel: +44 (0) 20 7408 4050

Toby Gibbs

James Thomas

Tavistock Communications

Tel: +44 (0) 20 7920 3150

Emily Moss

Nick Elwes

 

Questco Corporate Advisory - JSE Sponsor

Done Hattingh

Tel: +27 (63) 482 3802

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPKFBBQBKDKQB
Date   Source Headline
6th Dec 20247:00 amRNSCDI Monthly Movement
27th Nov 202410:49 amRNSResponse to ASX Aware Letter
22nd Nov 20247:00 amRNSLodgement of Cleansing Prospectus
20th Nov 20247:00 amRNSFinalisation of EPC Contract
11th Nov 20241:49 pmRNSTrading Halt, Amended Admission,Fundraising Update
7th Nov 20249:37 amRNSTrading Halt, & Amended Admission Date
5th Nov 202411:29 amRNSAnnouncement of Fundraise
5th Nov 20247:00 amRNSCDI Monthly Movement
31st Oct 20247:00 amRNSReview of Operations for Quarter to 30 Sept 2024
4th Oct 20247:00 amRNSCDI Monthly Movement
13th Sep 20247:00 amRNSFinancial Results for Half Year Ended 30 June 2024
4th Sep 20247:00 amRNSCDI Monthly Movement
23rd Aug 20242:00 pmRNSResults of General Meeting
6th Aug 20247:00 amRNSCDI Monthly Movement
31st Jul 20247:00 amRNSReview of Operations for Quarter to 30 June 2024
23rd Jul 20247:00 amRNSNotice of GM
3rd Jul 20247:00 amRNSCDI Monthly Movement
1st Jul 20249:30 amRNSFundraise of US$1,281,000
27th Jun 20247:00 amRNSAppointment of Non-Executive Director
24th Jun 20249:15 amRNSEPC Update
6th Jun 202411:15 amRNSResult of AGM
5th Jun 20247:00 amRNSCDI Monthly Movement
4th Jun 20247:00 amRNSRemote Access to AGM
23rd May 202411:06 amRNSResponse to ASX price and volume query
14th May 20249:00 amRNSResults of General Meeting & Issue of Shares
14th May 20247:00 amRNSCommencement of Trading on A2X Exchange
8th May 20247:00 amRNSCDI Monthly Movement
7th May 20247:00 amRNSSecondary Listing on A2X Exchange
3rd May 20247:00 amRNSNotice of 2024 AGM
29th Apr 20247:00 amRNSReview of Operations - Quarter ended 31 March 2024
15th Apr 20247:00 amRNSPDMR Grant of Options
12th Apr 20247:00 amRNSNotice of General Meeting
5th Apr 20247:00 amRNSCDI Monthly Movement
4th Apr 20247:00 amRNSAppointment of CEO
28th Mar 20247:15 amRNSFundraise – CLN Conversion & Chair Participation
28th Mar 20247:02 amRNSFinancial Results for Year Ended 31 December 2023
22nd Mar 20247:00 amRNSFundraise of US$ 530,000
6th Mar 20247:00 amRNSCDI Monthly Movement
9th Feb 20247:00 amRNSEPC Update
6th Feb 20247:00 amRNSCDI Monthly Movement
18th Jan 20247:00 amRNSReview of Operations for quarter ended 31 Dec 2023
5th Jan 20247:00 amRNSCDI Monthly Movement
29th Dec 20237:00 amRNSTotal Voting Rights
21st Dec 202311:00 amRNSTR-1: Notification of major holdings
11th Dec 20237:00 amRNSManagement changes
7th Dec 20231:00 pmRNSResults of General Meeting
7th Dec 20237:00 amRNSCDI Monthly Movement
30th Nov 20237:00 amRNSTotal Voting Rights
6th Nov 20237:00 amRNSNotice of General Meeting
3rd Nov 20237:05 amRNSCDI Monthly Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.